1. Home
  2. UG vs DYAI Comparison

UG vs DYAI Comparison

Compare UG & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • DYAI
  • Stock Information
  • Founded
  • UG 1942
  • DYAI 1979
  • Country
  • UG United States
  • DYAI United States
  • Employees
  • UG N/A
  • DYAI N/A
  • Industry
  • UG Package Goods/Cosmetics
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UG Consumer Discretionary
  • DYAI Health Care
  • Exchange
  • UG Nasdaq
  • DYAI Nasdaq
  • Market Cap
  • UG 45.5M
  • DYAI 54.4M
  • IPO Year
  • UG N/A
  • DYAI 2004
  • Fundamental
  • Price
  • UG $10.72
  • DYAI $1.50
  • Analyst Decision
  • UG
  • DYAI Strong Buy
  • Analyst Count
  • UG 0
  • DYAI 1
  • Target Price
  • UG N/A
  • DYAI $6.00
  • AVG Volume (30 Days)
  • UG 10.2K
  • DYAI 213.3K
  • Earning Date
  • UG 11-08-2024
  • DYAI 11-12-2024
  • Dividend Yield
  • UG 5.60%
  • DYAI N/A
  • EPS Growth
  • UG 38.11
  • DYAI N/A
  • EPS
  • UG 0.76
  • DYAI N/A
  • Revenue
  • UG $12,312,275.00
  • DYAI $3,364,548.00
  • Revenue This Year
  • UG N/A
  • DYAI $51.30
  • Revenue Next Year
  • UG N/A
  • DYAI $73.26
  • P/E Ratio
  • UG $14.14
  • DYAI N/A
  • Revenue Growth
  • UG 11.51
  • DYAI 13.82
  • 52 Week Low
  • UG $7.02
  • DYAI $0.93
  • 52 Week High
  • UG $16.25
  • DYAI $2.67
  • Technical
  • Relative Strength Index (RSI)
  • UG 63.40
  • DYAI 42.12
  • Support Level
  • UG $10.20
  • DYAI $1.45
  • Resistance Level
  • UG $10.91
  • DYAI $1.79
  • Average True Range (ATR)
  • UG 0.24
  • DYAI 0.24
  • MACD
  • UG 0.15
  • DYAI -0.05
  • Stochastic Oscillator
  • UG 86.63
  • DYAI 7.25

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About DYAI Dyadic International Inc.

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: